Centurium Capital
Overview
Centurium Capital is a leading private equity investment firm with a primary focus on consumer, business services, healthcare and technology sectors . The firm seeks to invest in control or significant minority private equity stakes with a particular focus on in-depth operation engagement to improve efficiency and solve structural deficiencies to create long term shareholder value .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Accro Bioscience Inc. | May 2026 | Series C | Co-investor |
| Excalipoint Therapeutics | Mar 2026 | Seed | Lead |
| Neolix | Oct 2025 | Series D | Co-investor |
| Iluvatar CoreX | Jan 2024 | Series D | Co-investor |
| NTX | Aug 2022 | Series C | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.